Dysmyelinating disorders
Citation, DOI, disclosures and article data
At the time the article was created Jeremy Jones had no recorded disclosures.
View Jeremy Jones's current disclosuresAt the time the article was last revised Daniel J Bell had no financial relationships to ineligible companies to disclose.
View Daniel J Bell's current disclosures- dysmyelination
- Dysmyelinating diseases
- Dysmyelinating disease
- Dysmyelinating disorder
Dysmyelinating disorders are a subset of white matter disorders characterized by abnormal myelination 1. They include numerous inherited conditions that are characterized by a defective structure and function of the myelin sheath 2.
Terminology
Dysmyelinating disorders are often thought of being synonymous with leukodystrophies, and traditionally they have been thought of as being distinct from demyelinating disorders where there is destruction or damage of previously normal myelination.
It is now apparent that many of the more common leukodystrophies (e.g. metachromatic leukodystrophy, X-linked adrenoleukodystrophy) have a significant demyelinating component 3,4.
As such it is best to think of dysmyelinating and demyelinating as describing the dominant process involved in the larger group of leukodystrophies.
References
- 1. William E. Brant, Clyde A. Helms. Fundamentals of Diagnostic Radiology. (2007) ISBN: 9780781761352 - Google Books
- 2. Richard A. Prayson. Neuropathology Review. (2008) ISBN: 9781588298959 - Google Books
- 3. Cheon J, Kim I, Hwang Y et al. Leukodystrophy in Children: A Pictorial Review of MR Imaging Features. Radiographics. 2002;22(3):461-76. doi:10.1148/radiographics.22.3.g02ma01461 - Pubmed
- 4. Thomas A. Fleisher, William T. Shearer, Anthony J. Frew et al. Clinical Immunology,Principles and Practice (Expert Consult - Online and Print),4. (2013) ISBN: 9780723436911 - Google Books
Incoming Links
Related articles: White matter disorders
- white matter
- normal myelination
- terminology
-
white matter disorders
-
demyelination
- general articles
- acute disseminated encephalomyelitis (ADEM)
- acute hemorrhagic encephalomyelitis (AHEM)
- anti-MOG associated encephalomyelitis (MOGAD)
- neuromyelitis optica spectrum disorder (NMOSD)
-
multiple sclerosis (MS)
-
McDonald diagnostic criteria for MS (2017 revision)
- previous 2016 MAGNIMS consensus
- signs
- variants
-
McDonald diagnostic criteria for MS (2017 revision)
- radiologically isolated syndrome (RIS)
- clinically isolated syndrome (CIS)
- astrocytopathies
- leukoaxonopathies
- early-onset neuronal degenerative disorders
- giant axonal neuropathy
- hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)
- hypomyelination with congenital cataract
- leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
- hypomyelination with brainstem and spinal cord involvement and leg spasticity
- pol III-related leukodystrophies
- leukovasculopathies
- CADASIL
- CARASIL
- cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL)
- cerebral amyloid angiopathy
- COL4A1 brain small-vessel disease
- Fabry disease
- heterozygous HTRA1-related cerebral small vessel disease
- leukoencephalopathy with calcifications and cysts (Labrun syndrome)
- pontine autosomal dominant microangiopathy with leukoencephalopathy (PADMAL)
- retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
- microgliopathies
- myelin disorders
- hypomyelination
- demyelination
- myelin vacuolisation
- other
- adult polyglucosan body disease
- adult-onset autosomal dominant leukodystrophy
- cerebrotendinous xanthomathosis
- cystic leukoencephalopathy without megalencephaly
- L-2-hydroxyglutaric aciduria
-
lysosomal storage diseases
- free sialic acid storage disorders (e.g. Salla disease)
- Niemann-Pick disease
- peroxisomal disorders
- Sjögren-Larsson syndrome
-
demyelination